Atlas Trials

Efficacy and Safety of Eltrombopag + Tacrolimus in Chinese Refractory or Relapsed Aplastic Anemia Patients

Clinical trial NCT04403321 · COMPLETED

Trial details

NCT number
NCT04403321
Sponsor
Peking Union Medical College Hospital
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Aplastic AnemiaDrug Effect
Start date
2020-07-01
Primary completion
2022-07-30
Enrollment
114

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.